These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, Kim H, Jon S, Chen X, Lee KC. Int J Pharm; 2011 Jan 17; 403(1-2):285-91. PubMed ID: 21035530 [Abstract] [Full Text] [Related]
9. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells. Li Q, Liu C, Zhao X, Zu Y, Wang Y, Zhang B, Zhao D, Zhao Q, Su L, Gao Y, Sun B. Int J Nanomedicine; 2011 Jan 17; 6():397-405. PubMed ID: 21499429 [Abstract] [Full Text] [Related]
13. Albumin Based Nanomedicine for Enhancing Tacrolimus Safety and Lymphatic Targeting Efficiency. Zhang Y, Pan J, Li H, Yu D, Wu T, Wang L, Wang Y, Zhou L, Zheng S. J Biomed Nanotechnol; 2019 Jun 01; 15(6):1313-1324. PubMed ID: 31072438 [Abstract] [Full Text] [Related]
14. Pyrazolo[3,4-d]pyrimidines-loaded human serum albumin (HSA) nanoparticles: Preparation, characterization and cytotoxicity evaluation against neuroblastoma cell line. Fallacara AL, Mancini A, Zamperini C, Dreassi E, Marianelli S, Chiariello M, Pozzi G, Santoro F, Botta M, Schenone S. Bioorg Med Chem Lett; 2017 Jul 15; 27(14):3196-3200. PubMed ID: 28558969 [Abstract] [Full Text] [Related]
15. Development and effects of tacrolimus-loaded nanoparticles on the inhibition of corneal allograft rejection. Wu Q, Liu D, Zhang X, Wang D, DongYe M, Chen W, Lin D, Zhu F, Chen W, Lin H. Drug Deliv; 2019 Dec 15; 26(1):290-299. PubMed ID: 30895841 [Abstract] [Full Text] [Related]
17. Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes. Kalam MA, Alshamsan A. Biomed Pharmacother; 2017 Oct 15; 94():402-411. PubMed ID: 28772219 [Abstract] [Full Text] [Related]
18. Albumin-coupled methotrexate (MTX-HSA) is a new anti-arthritic drug which acts synergistically to MTX. Fiehn C, Müller-Ladner U, Gay S, Krienke S, Freudenberg-Konrad S, Funk J, Ho AD, Sinn H, Wunder A. Rheumatology (Oxford); 2004 Sep 15; 43(9):1097-105. PubMed ID: 15199219 [Abstract] [Full Text] [Related]
19. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations. Jain S, Addan R, Kushwah V, Harde H, Mahajan RR. Int J Pharm; 2019 May 01; 562():96-104. PubMed ID: 30902706 [Abstract] [Full Text] [Related]